Akebia Therapeutics
AKBA
$1.34
Share price
0.75%
Change (1 day)
47.25%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) - Total debt
Total debt on the balance sheet as of December 2023 : $48.12 M
According to Akebia Therapeutics's latest financial reports the company's total debt is $48.12 M. A company’s total debt is the sum of all current and non-current debts.
Akebia Therapeutics - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $48.12 M | -51.77% |
| 2022-12-31 | $99.78 M | -26.66% |
| 2021-12-31 | $0.13 B | 7.73% |
| 2020-12-31 | $0.12 B | 16.58% |
| 2019-12-31 | $0.10 B | 622.15% |
| 2018-12-31 | $15 M | |
| 2013-12-31 | $0.01 M | |
| 2012-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 60,854.68% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 56,598.74% | 🇨🇭 Switzerland |
 Amgen AMGN | $64.61 B | 134,171.94% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.11 B | 144.75% | 🇺🇸 USA |